Kevin C. Johnson, Ph.D.

Postdoctoral Associate

Leverages genomic technologies to investigate brain tumor biology and disease evolution.

Visit The Verhaak Lab

Connect with me:

About Kevin C. Johnson, Ph.D.

Dr. Johnson has a Ph.D. in Experimental and Molecular Medicine from Dartmouth where he received comprehensive training in quantitative and basic biomedical sciences. He has strong interest in the dynamic epigenomic landscape of glioma cells during disease progression and recurrence.

DOWNLOAD CV

Education and Experience

2016 – present Postdoctoral Research Fellow

The Jackson Laboratory for Genomic Medicine

2011 – 2016 Ph.D., Experimental and Molecular Medicine

Dartmouth College

2007 – 2011 B.S., Food Science and Technology,

University of Massachusetts – Amherst

Honors and Accomplishments

2016 Neukom Prize for Outstanding Graduate Research in Computational Science

Albert J. Ryan Predoctoral Fellowship

Selected Publications

View full list of publications

Press ReleaseSeptember 21, 2018
New way to target advanced breast cancers
New research shows that a cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.
Search MagazineSeptember 11, 2018
Non-coding DNA is not junk after all
Assistant Professor Christine Beck, Ph.D., is uncovering how recurring sequences in our genomes might shed light on genome stability, as well as diseases like cancer.
Press ReleaseSeptember 04, 2018
Using mathematical modeling to target infections
When an otherwise harmless fungus like Aspergillus fumigatus invades the lungs of people with compromised immune systems, it can cause severe respiratory problems. A new NIH grant will employ specialized mathematical and computer modeling to improve understanding of our biological defense system.
Search MagazineAugust 14, 2018
Understanding our inheritance
To find out more about the complexities of inheritance, JAX spoke with author and New York Times columnist Carl Zimmer, who frequently writes about genetics and evolution.

Research HighlightSeptember 11, 2018
Exploring zinc finger proteins
The National Institute of General Medical Sciences has awarded Petko Petkov a four-year grant totaling $1,385,337 to exploit the new methods he has developed to profile and investigate zinc finger proteins and their binding sites.
Press ReleaseSeptember 05, 2018
A better combination therapy for leukemias
A new approach to treating some leukemias could deliver a one-two punch to the cancer cells without harming normal tissue.
Tech CornerAugust 21, 2018
Learn about CRISPR, Cre-lox through self-paced online JAX MiniCourses
New certificate program introduces basic genetic engineering techniques.
Press ReleaseAugust 01, 2018
A RACIPE for success
New five-year, $2.2M outstanding investigator grant to Mingyang Lu will support systems biology algorithm approach.